Black Diamond Therapeutics
BDTX
BDTX
94 hedge funds and large institutions have $124M invested in Black Diamond Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less capital invested
Capital invested by funds: $206M → $124M (-$82.3M)
67% less call options, than puts
Call options by funds: $87K | Put options by funds: $260K
Holders
94
Holding in Top 10
–
Calls
$87K
Puts
$260K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$1.1M | |
| 3 | +$308K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$246K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$209K |
Top Sellers
| 1 | -$6.43M | |
| 2 | -$4.44M | |
| 3 | -$2.29M | |
| 4 |
HF
HRT Financial
New York
|
-$604K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$586K |